Pre-operative Immunotherapy Combination Strategies in Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor-positive Breast Cancer
Interventions: DRUG: Atezolizumab|DRUG: Cobimetinib|DRUG: Ipatasertib|DRUG: Bevacizumab
Sponsor: Queen Mary University of London
Collaborators: Kliniken Essen-Mitte|MedSIR|Asan Medical Center|Hoffmann-La Roche